Accendra Health, Inc.

Healthcare · Medical - Distribution

Overall research band Weak

Quality Very weak

Valuation Mixed

Balance sheet Very weak

Market confirmation Not available

One-minute company read

What this report can tell you now

What the company does

Accendra Health, Inc., formerly known as Owens & Minor, Inc., is a global provider of healthcare solutions headquartered in Glen Allen, Virginia. The company operates through two main divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment supplies medical and surgical products, including both branded and proprietary items, and offers services such as supplier relationship management, analytics, inventory optimization, clinical supply oversight, logistics, and marketing support to healthcare providers and manufacturers. The Patient Direct segment focuses on at-home patient care, providing products and services for diabetes management, home respiratory support, sleep apnea therapy, and other specialized medical needs like ostomy, wound, urological, and incontinence care. Accendra Health serves a broad range of customers, including healthcare systems, hospitals, surgical centers, physician practices, and also reaches end-users through third-party distributors.

The current research profile is Industrial Company. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC8.4%Model input; read with the evidence status and period context.

Operating margin8.0%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years-27.1%Model input; read with the evidence status and period context.

FCF margin-11.0%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.